Physician profile
Matthew Goodwin
NPI 1841407301
$9,327.22
in general payments reported to CMS, 2019-2025
23 companies · $1,010 in 2025
The $1,010 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,927 · 2020: $436 · 2021: $959 · 2022: $1,446 · 2023: $822 · 2024: $1,728 · 2025: $1,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,559.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,616.33 | 2019-2022 | |
| Tela Bio, INC. | $1,754.94 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Sientra, INC. | $1,089.00 | 2019-2022 | |
| Mentor Worldwide LLC | $963.32 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Spineart USA INC | $590.00 | 2024 | |
| Abbvie INC. | $550.03 | 2023-2025 | |
| Musculoskeletal Transplant Foundation INC. | $175.80 | 2024 | |
| Sanara Medtech INC. | $173.20 | 2025 | Celleraterx |
| Lsi Solutions INC | $157.51 | 2022-2024 | Fornisee |
| Acera Surgical, INC. | $152.28 | 2025 | Restrata Wound Matrix |
| Dilon Technologies, INC. | $141.51 | 2023-2024 | Hemoblast Bellows |
| Vertex Pharmaceuticals Incorporated | $124.99 | 2025 | |
| Heron Therapeutics, INC. | $121.87 | 2024 | Aponvie, Zynrelef |
| Covidien LP | $114.27 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $113.20 | 2021-2024 | Exparel |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solta Medical, A Division of Bausch Health US, LLC | $109.52 | 2025 | |
| Coopersurgical, INC. | $82.23 | 2020-2022 | |
| Integra Lifesciences Corporation | $67.18 | 2023-2025 | Integra, Durasorb Monofilament Mesh, Surgimend |
| Merz North America, INC. | $63.56 | 2021-2025 | |
| Galderma Laboratories, L.P. | $57.02 | 2021-2022 | |
| Ethicon US, LLC | $55.55 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $35.27 | 2023 | Seglentis |
| Motiva USA, LLC | $18.64 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Goodwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.